Skip to content
  • Home
  • Book Bag: 0 items (Full)
    • English
    • 日本語
    • 中文(简体)
    • 中文(繁體)
    • اللغة العربية
  • About
Advanced
  • Correction: HMGA1 augments pal...
  • Cite this
  • Text this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Add to Book Bag Remove from Book Bag
  • Permanent link

Correction: HMGA1 augments palbociclib efficacy via PI3K/mTOR signaling in intrahepatic cholangiocarcinoma

Bibliographic Details
Published in:Biomarker Research
Main Authors: Zhipeng Li, Huaxin Zhou, Zhijia Xia, Tong Xia, Gang Du, Strohmer Dorothee Franziska, Xiaoming Li, Xiangyu Zhai, Bin Jin
Format: Article
Language:English
Published: BMC 2024-02-01
Online Access:https://doi.org/10.1186/s40364-024-00574-0
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://doi.org/10.1186/s40364-024-00574-0

Similar Items

  • HMGA1 augments palbociclib efficacy via PI3K/mTOR signaling in intrahepatic cholangiocarcinoma
    by: Zhipeng Li, et al.
    Published: (2023-03-01)
  • UCK2 promotes intrahepatic cholangiocarcinoma progression and desensitizes cisplatin treatment by PI3K/AKT/mTOR/autophagic axis
    by: Xiwen Wu, et al.
    Published: (2024-08-01)
  • Overexpression of HMGA1 confers radioresistance by transactivating RAD51 in cholangiocarcinoma
    by: Jianping Song, et al.
    Published: (2021-10-01)
  • Dual blockage of PI3K-mTOR and FGFR induced autophagic cell death in cholangiocarcinoma cells
    by: Narumon Mahaamnad, et al.
    Published: (2024-05-01)
  • Tanshinone IIA affects the malignant growth of Cholangiocarcinoma cells by inhibiting the PI3K-Akt-mTOR pathway
    by: Huayuan Liu, et al.
    Published: (2021-09-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs